Fact-checked by Grok 2 weeks ago

Delayed sleep phase disorder

Delayed sleep phase disorder (DSPD), also known as delayed sleep-wake phase disorder (DSWPD), is a sleep-wake disorder characterized by a persistent delay in the normal timing of sleep onset, mid-sleep, and wake times, typically by two or more hours beyond conventional social schedules, resulting in an inability to fall asleep and awaken at desired times despite adequate opportunity for sleep. Individuals with DSPD often report difficulty initiating sleep before 2:00 a.m. to 6:00 a.m., followed by prolonged and challenges waking up early for school, work, or other obligations, which can lead to , reduced concentration, impaired academic or occupational performance, and mood disturbances such as or anxiety. Recent studies (as of 2025) highlight stronger links to depressive symptoms in . The disorder is distinguished from voluntary late-night habits by the fact that sleep occurs normally and at full duration once initiated, but the delayed phase causes misalignment with societal demands. The etiology of DSPD involves a combination of genetic predispositions, such as mutations in circadian clock genes like CRY1, which can prolong the intrinsic circadian period, and environmental factors including irregular sleep schedules, insufficient exposure to morning light, evening light overuse from screens, or . It is more prevalent in adolescents and young adults, affecting 7% to 16% of this group, compared to 0.17% to 1% in the general population, with onset often occurring in puberty and a higher incidence among those with neurodevelopmental conditions like ADHD or autism spectrum disorder, and variable gender prevalence. Diagnosis typically relies on clinical history, sleep diaries, actigraphy to monitor rest-activity patterns, and sometimes polysomnography to rule out other sleep disorders, with criteria outlined in the International Classification of Sleep Disorders requiring the delay to cause significant distress or impairment for at least three months. Treatment focuses on phase advancement through behavioral interventions like sleep hygiene education, morning bright light therapy (e.g., 10,000 lux for 30-60 minutes), and pharmacological options such as timed low-dose melatonin (0.5-5 mg) administered in the evening, as endorsed by the American Academy of Sleep Medicine guidelines; chronotherapy may be considered in refractory cases.

Definition and classification

Core definition

Delayed sleep phase disorder (DSPD), also known as delayed sleep-wake phase disorder (DSWPD), is a sleep-wake disorder characterized by a persistent misalignment between an individual's endogenous and the required sleep-wake schedule imposed by societal or occupational demands. This misalignment results in a preferred sleep onset and offset that are typically delayed by two or more hours relative to conventional norms, often leading individuals to naturally fall asleep after 2 a.m. and awaken after 10 a.m. when given the opportunity. The disorder is distinguished from other sleep disturbances by its chronic nature, persisting for more than three months, and by the absence of contributing factors such as inadequate practices, substance use, or other medical, neurological, or psychiatric conditions. Core definitional symptoms include significant difficulty initiating at conventional evening times, contrasted with the ability to achieve —typically 7 to 9 hours—and quality once onset occurs at the delayed preferred time. When compelled to adhere to earlier wake times, individuals experience pronounced morning and , impairing alertness and performance. In the , third edition (ICSD-3), DSPD is formally defined by criteria that emphasize a delayed endogenous circadian , confirmed through methods such as prospective logs or monitoring over at least seven days, demonstrating the consistent delay in timing relative to desired or socially appropriate schedules. This diagnostic framework ensures the condition is not merely a transient shift but a stable disruption in circadian .

Diagnostic criteria

The diagnosis of delayed sleep-wake phase disorder (DSWPD) is established using the criteria outlined in the , Third Edition, Text Revision (ICSD-3-TR), published by the (AASM). These criteria require a significant delay in the timing of the major sleep episode relative to desired or socially acceptable sleep and wake times, leading to symptoms of evening and/or morning sleepiness or impairment. The sleep disturbance must cause significant distress or impairment in social, occupational, or other areas of functioning. The specific ICSD-3-TR criteria for DSWPD are as follows:
  • Criterion A: A significant delay in the major episode (in the evening and/or early morning) relative to desired or required onset and wake times, as evidenced by a or recurrent pattern of one or both of the following: (1) an inability to fall asleep at the desired time; (2) an inability to awaken at the desired or required time.
  • Criterion B: The symptoms have been present for at least 3 months.
  • Criterion C: When not constrained by required wake times, the individual is able to at an appropriate duration but at a delayed phase relative to a conventional , and reports improved .
  • Criterion D: The is supported by logs and, if possible, , documenting the habitual delayed period on both work/school days and free days for at least 7 days (preferably 14 days or longer).
  • Criterion E: The disturbance is not better explained by another , coexisting medical or neurologic disorder, , medication use, or .
Supporting assessments are essential to confirm the and rule out other conditions. Sleep diaries, maintained for a minimum of 7 to 14 days (ideally including both work/ days and free days), provide subjective on habitual onset, offset, and quality, demonstrating the consistent delay. , an objective wearable device that monitors rest-activity cycles over at least 7 to 14 days, corroborates the diary findings by showing a stable but delayed -wake pattern, with high reliability for disorders. Dim melatonin onset (DLMO) testing, performed via serial or samples under controlled dim conditions, measures the and typically reveals a delay of more than 2 hours compared to normal populations (e.g., DLMO after 10 PM in adults); however, a delayed DLMO is not observed in all cases (e.g., up to 40% may have normal timing). Subjective chronotype assessment aids in identifying extreme eveningness as a phase marker. The Horne-Östberg Morningness-Eveningness (MEQ), a 19-item self-report scale scoring individuals on a from definite morning to definite evening types, is commonly used for screening, with scores below indicating potential DSWPD. Similarly, the Chronotype (MCTQ) evaluates mid-sleep time on free days as a proxy for , showing delayed values (e.g., after 5 AM) in DSWPD patients. Diagnosis requires evidence of persistence and significant impairment in , occupational, or other areas of functioning, DSWPD from transient or behavioral delays such as those due to lifestyle factors.

Signs and symptoms

Primary symptoms

Individuals with delayed sleep phase disorder (DSPD) typically experience significant difficulty initiating at conventional hours, often exhibiting a prolonged sleep latency exceeding one hour despite feeling tired earlier in the evening. This is specific to attempting at socially expected times, such as 10-11 PM, and resolves without distress once the individual adheres to their naturally delayed schedule, allowing normal duration and quality thereafter. When forced to conform to standard wake times, such as for work or school, affected individuals report or fatigue due to truncated sleep, though they function normally and feel refreshed if permitted to maintain their late sleep-wake cycle. Circadian misalignment manifests as peak periods of , cognitive performance, and physical occurring in the late evening or nighttime, with pronounced difficulty awakening before noon and a corresponding dip in morning functionality. Associated somatic complaints often arise from accumulated under conventional schedules, including headaches, , and reduced appetite. These physical symptoms, while not universal, underscore the physiological strain of misalignment and may briefly overlap with mood alterations like mild anxiety or low in some cases.

Daily impacts

Individuals with delayed sleep phase disorder (DSPD) frequently encounter substantial occupational and educational challenges stemming from the mismatch between their natural late sleep onset and the early schedules of most work and environments. This misalignment often results in chronic partial , leading to daytime fatigue, impaired concentration, and reduced cognitive performance, which manifest as frequent , , and lower productivity. For instance, adolescents diagnosed with DSPD demonstrate significantly higher rates of school non-attendance compared to their peers without the disorder, alongside poorer academic grades due to these functional impairments. In professional settings, adults with DSPD report greater in occupational functioning, including difficulties maintaining consistent attendance and meeting performance demands, which can heighten the risk of underachievement or job instability. The disorder also imposes considerable social and relational strain, as individuals often find it challenging to participate in daytime activities aligned with societal norms, fostering a sense of from peers and community events. This desynchronization frequently precipitates conflicts with members and , who may view the persistent late bedtime and morning difficulties as willful disregard or rather than a biological . Studies indicate that family misunderstandings and interpersonal tensions are common, with up to 34% of DSPD patients experiencing notable family conflicts directly attributable to scheduling discrepancies. Such relational can erode support networks and exacerbate feelings of in daily interactions. Lifestyle adaptations among those with DSPD tend to reinforce the circadian delay, as irregular patterns of , exercise, and light exposure become normalized to accommodate late-night alertness. For example, later sleep timing is associated with delayed and more variable , which disrupts metabolic cues and perpetuates the phase shift by altering peripheral . Similarly, often shifts to evening hours, potentially intensifying exposure to evening light that inhibits onset and hinders earlier attempts. These compensatory habits, while providing short-term relief, contribute to a cycle of inconsistency that complicates adherence to conventional routines. Psychologically, the ongoing daily disruptions from DSPD engender frustration and a diminished of self-worth, as individuals internalize societal judgments of their sleep preferences as personal shortcomings or lack of discipline. This perceived laziness leads to lowered and strained self-perception, particularly when efforts to conform to standard schedules fail repeatedly, fostering a of inadequacy in fulfilling social and professional roles. highlights that these experiences correlate with reduced and heightened emotional distress tied to the inability to align with expected norms.

Pathophysiology

Genetic factors

Twin studies have estimated the of , a key trait underlying delayed sleep phase disorder (DSPS), at 40-54%, indicating a substantial genetic contribution to individual differences in sleep timing preferences. This genetic influence is evident in the stronger concordance of sleep phase preferences among monozygotic twins compared to dizygotic twins, supporting a polygenic basis where multiple genetic variants collectively modulate circadian timing. Familial patterns of DSPS often exhibit autosomal dominant inheritance, with evening clustering in affected pedigrees, as observed in families segregating specific clock gene s. For instance, a splice-site in the CRY1 gene (c.1657+3A>C), which causes skipping of 11 and an in-frame deletion of 24 , has been identified in multiple families with DSPS, leading to a lengthened circadian period and delayed sleep onset through enhanced transcriptional repression. Similarly, rare variants in PER2, such as the p.Val1205Met, show autosomal dominant segregation in DSPS cases, disrupting PER2's role in stabilizing the circadian feedback loop. Variants in other core clock genes further contribute to DSPS susceptibility. A variable-number tandem repeat polymorphism in PER3 (PER3^VNTR), particularly the shorter 4-repeat , is overrepresented in DSPS patients and associated with extreme evening chronotypes by altering PER3's oscillatory function in the . The CLOCK gene's 3111T/C polymorphism (rs1801260), where the C predominates, correlates with delayed phase and evening preference by influencing CLOCK-BMAL1 heterodimer activity and transcriptional activation of circadian output genes. Genome-wide association studies (GWAS) up to 2024 have advanced understanding by identifying polygenic risk loci for extreme chronotypes relevant to DSPS. These efforts, analyzing hundreds of thousands of participants, have pinpointed variants influencing clock gene amplitude and contributing to delayed phase extremes. Such findings underscore the molecular disruption of circadian regulation in DSPS, with ongoing research emphasizing the interplay of rare mutations and common variants.

Circadian and neurobiological mechanisms

Delayed sleep phase disorder (DSPS) involves dysfunction in the (SCN), the primary circadian pacemaker located in the , leading to delayed of the internal clock to environmental cues. The SCN receives photic input directly from intrinsically photosensitive cells via the , which synchronizes circadian rhythms to the light-dark cycle. In DSPS, this is delayed due to insufficient exposure to phase-advancing morning light or excessive exposure to phase-delaying evening light, resulting in a persistent shift of the circadian pacemaker phase. Key hormonal rhythms regulated by the SCN are also postponed in DSPS. secretion, which signals the onset of the biological night, exhibits a delayed dim light onset (DLMO) typically 6-8 hours later than in individuals with normal sleep phases, often occurring between and 4 a.m. compared to 8-10 p.m. in controls. Similarly, rhythms, which promote , show postponed peaks in the early morning, contributing to difficulties in morning and perpetuating the delayed sleep-wake cycle. Neurotransmitter systems interact with circadian mechanisms in DSPS, influencing sleep drive and behavioral timing. Reduced evening sensitivity to serotonin, a key modulator of mood and onset, may impair the transition to at conventional times, while altered signaling disrupts reward processing and motivation during typical waking hours, exacerbating daytime impairment. These changes likely arise from interactions between the SCN and broader neural networks, though genetic influences on clock genes can modulate such dynamics. Recent studies using functional MRI (fMRI) have highlighted altered in DSPS, with disruptions in networks involved in circadian and sleep-wake transitions, providing insights into the neurobiological underpinnings of the disorder.

Comorbidities

Psychiatric conditions

Delayed sleep phase disorder (DSPD) exhibits significant with various psychiatric conditions, reflecting bidirectional influences where circadian misalignment can precipitate or exacerbate symptoms, while underlying may disrupt sleep-wake . Prevalence rates of psychiatric disorders among individuals with DSPD are notably elevated compared to the general population, with mood and neurodevelopmental disorders being particularly common. Depression is common in DSPD, with comorbidity rates reported up to 64% in clinical samples. This comorbidity is bidirectional: chronic from DSPD can intensify depressive symptoms such as by impairing reward processing and emotional regulation, while depressive episodes often feature delayed sleep phase as a core feature. Phase advancement interventions, such as chronotherapy, have been shown to alleviate depressive symptoms in DSPD patients, underscoring the causal role of circadian disruption. Attention-deficit/hyperactivity disorder (ADHD) shares a strong association with DSPD, with up to 75% of adults diagnosed with ADHD in childhood exhibiting delayed circadian rhythms or evening chronotypes. This overlap manifests in a delayed onset, which correlates with heightened inattention and during conventional daytime hours. The prevalence of DSPD in ADHD populations ranges from 26% to 78%, far exceeding general population estimates of 0.2-10%. Autism spectrum disorder () also shows strong with DSPD, with sleep disturbances including delayed phases reported in 50-80% of individuals with . Obsessive-compulsive disorder (OCD) and anxiety disorders also frequently coexist with DSPD, with 17.6-42% of OCD patients meeting criteria for delayed sleep-wake phase disorder, compared to near-zero rates in controls. Ritualistic behaviors in OCD and anxiety can compromise by prolonging bedtime routines, while the late-night peak in DSPD often amplifies obsessive thoughts and rumination during prolonged wakefulness. Trait anxiety further mediates this relationship, heightening symptoms in comorbid cases. Recent longitudinal studies from 2023-2025 indicate that DSPD is associated with increased risk of mood episode relapse in and may contribute to symptom progression in at-risk , such as offspring of parents. Approximately 10% of patients with disturbances fulfill DSPD criteria, often presenting younger and with more severe delays.

Physical health associations

Delayed sleep phase disorder (DSPD) is associated with an increased risk of and , primarily due to irregular eating patterns stemming from late-night sleep schedules that disrupt meal timing and promote caloric intake during unconventional hours. Circadian misalignment in DSPD contributes to metabolic dysregulation, including altered rhythms that reduce signals and enhance , thereby facilitating . Research indicates a bidirectional link, where delayed sleep patterns exacerbate adiposity, and obesity in turn may worsen sleep phase delays through inflammatory pathways. Following (TBI), DSPD can emerge as a post-traumatic sleep disturbance, with disorders affecting approximately 20-40% of individuals depending on injury severity and assessment timing. Case reports and reviews document instances where closed lead to persistent delayed sleep-wake cycles, often persisting for years post-injury. Studies from 2023 to 2025 have identified disruptions, including DSPD-like delays, in patients, linked to and chronic fatigue syndromes. Sleep disturbances, encompassing phase delays, are reported in a substantial subset of long-haul cases, with estimates for circadian alterations reaching up to 15% in affected cohorts. Beyond these, DSPD elevates cardiovascular risks through chronic poor sleep quality and misalignment, which correlate with higher incidences of and . Adults with DSPD, especially those with comorbid attention-deficit/hyperactivity disorder, exhibit elevated markers of , underscoring the need for integrated monitoring.

Diagnosis

Clinical evaluation

The clinical evaluation of delayed sleep-wake phase disorder (DSWPD) begins with a comprehensive history-taking process to establish the patient's sleep-wake patterns and . Clinicians typically obtain detailed sleep-wake logs, often spanning at least 7 to 14 days, where patients record , sleep onset, awakenings, and wake times to identify consistent delays in the sleep phase relative to conventional schedules. assessment is conducted using validated tools such as the Morningness-Eveningness Questionnaire (MEQ), which categorizes individuals as evening types based on preferences for activity and alertness timing, supporting the identification of an intrinsic delay. Additionally, the history includes screening for substances and medications that could mimic or exacerbate phase delays, such as , , , or hypnotics, to rule out external influences on circadian alignment. Objective measures complement subjective reports to confirm the delayed rest-activity cycle. Wrist actigraphy, a noninvasive device worn for 7 to 14 days, objectively plots movement patterns to delineate sleep onset and offset, often revealing delays of 2 hours or more beyond societal norms. Dim melatonin onset (DLMO) assessment, via salivary sampling under dim light conditions, can precisely measure the circadian phase and confirm the delay when needed. (PSG) is not routinely required for DSWPD but may be employed if initial assessments suggest comorbid sleep-disordered breathing or other conditions necessitating exclusion through overnight monitoring of brain waves, oxygen levels, and respiratory events. Standardized questionnaires help quantify the functional consequences of DSWPD. The Epworth Sleepiness Scale (ESS) evaluates daytime sleepiness by asking patients to rate their likelihood of dozing in eight common situations, with scores above 10 indicating excessive impact that correlates with delayed phase complaints. The Pittsburgh Sleep Quality Index (PSQI), while primarily assessing overall sleep quality over the past month, can be adapted in conjunction with sleep logs to highlight phase-specific disruptions, such as prolonged sleep latency and inefficiency due to misalignment. These tools align with the International Classification of Sleep Disorders (ICSD) criteria for DSWPD diagnosis. Evaluation often involves a multidisciplinary team, including specialists, to integrate findings from history, , and questionnaires into a cohesive . Since 2020, has facilitated remote monitoring, enabling virtual consultations and data review to enhance accessibility for patients with scheduling challenges.

Differential diagnosis

Delayed sleep-wake phase disorder (DSWPD) must be differentiated from other sleep-wake disorders and conditions that present with similar complaints of delayed sleep onset and daytime . A key feature of DSWPD is a stable, entrained that is persistently delayed by at least two hours relative to conventional sleep-wake times, allowing normal sleep duration and quality when the schedule aligns with the internal clock. Diagnosis relies on excluding mimics through clinical history, sleep diaries, , and, when available, of circadian markers like dim light melatonin onset (DLMO), which remains consistently delayed and stable over weeks in DSWPD. Non-24-hour sleep-wake disorder (non-24) is distinguished from DSWPD by its free-running , typically with a cycle longer than 24 hours, leading to progressive daily delays in sleep onset that do not to the 24-hour day. In contrast, individuals with DSWPD maintain to the light-dark cycle but at a delayed , resulting in consistent timing relative to their internal clock rather than progressive drifting. DLMO assessments show stability in DSWPD but gradual shifts over days to weeks in non-24, aiding differentiation. Primary insomnia differs from DSWPD in that patients experience difficulty initiating or maintaining , often with reduced total time, regardless of schedule timing, whereas those with DSWPD achieve normal duration (typically 7-9 hours) and quality when permitted to follow their delayed preferences. This distinction is critical, as misdiagnosis of DSWPD as can lead to inappropriate treatments like hypnotics, which fail to address the underlying circadian misalignment. In adolescents, delayed sleep patterns are common due to physiological shifts in circadian timing during , often resolving by the early 20s without evolving into chronic DSWPD; however, true DSWPD is diagnosed when the delay is chronic (lasting at least three months) and causes significant distress or impairment, distinguishing it from transient developmental phases. Other mimics include lifestyle-induced "" from irregular schedules or self-imposed late nights, and shift work disorder, where symptoms arise from external work demands rather than intrinsic rhythm delay and resolve with schedule normalization. Differentiation from these involves demonstrating DLMO stability over multiple weeks, confirming an endogenous rather than situational cause.

Management

Behavioral and chronotherapeutic approaches

Behavioral and chronotherapeutic approaches to managing delayed sleep phase disorder (DSPD) emphasize non-pharmacological strategies aimed at realigning the endogenous with societal sleep-wake demands through timed environmental cues and lifestyle modifications. These methods target the core phase delay in the sleep-wake cycle, typically by advancing the or enforcing consistent schedules to promote . Chronotherapy involves systematically shifting the bedtime and wake time in a progressive manner to reset the . In the classic phase-delay chronotherapy, bedtime is delayed by approximately 3 hours each day until the desired onset aligns with conventional hours, often completing a full cycle in about 7 days, after which the schedule is maintained to prevent . This approach leverages the body's natural tendency for phase delays under free-running conditions and has shown initial success in achieving , though long-term adherence is crucial to avoid recurrence of the delay. Light therapy utilizes timed exposure to bright light to advance the circadian phase in individuals with DSPD. Morning administration of bright light at an intensity of 10,000 for 30 to 60 minutes upon awakening suppresses production and shifts the earlier, helping to normalize sleep onset. Complementing this, avoidance of blue-enriched light in the evening—through the use of blockers or dim red lighting—prevents further phase delays by minimizing suppression of evening onset. Systematic reviews indicate that such protocols are effective for phase advancement when consistently applied. Sleep hygiene practices form the foundation of behavioral management by promoting a stable sleep environment and routine tailored to circadian realignment. Key elements include enforcing a fixed daily regardless of weekend variations, avoiding naps to consolidate nighttime , and creating a dark, cool free from electronic distractions. (CBT-I), adapted for DSPD, incorporates techniques—such as using the bed only for —and to address unhelpful beliefs about timing, often combined with chronotherapy elements to enhance phase advance. Randomized trials have demonstrated that adapted CBT-I improves and overall efficiency in adolescents and adults with DSPD. As of 2025, digital tools have enhanced adherence to these approaches through app-based tracking and (VR) simulations. Mobile applications utilize sensors to monitor patterns and provide personalized recommendations for exposure and schedule adjustments, enabling feedback on circadian alignment.

Pharmacological interventions

Pharmacological interventions for delayed sleep phase disorder (DSPD) primarily focus on agents that advance the or facilitate onset, with serving as the cornerstone treatment. Exogenous , a that regulates the sleep-wake cycle, is administered in low doses ranging from 0.5 to 5 mg, typically 5 to 7 hours before the preferred to maximize phase advancement of the dim light melatonin onset (DLMO). This timing aligns with the for , where evening administration promotes a shift toward earlier timing. Randomized controlled trials (RCTs) have demonstrated that such regimens can advance onset and circadian phase by 1 to 2 hours; for instance, one double-blind RCT involving 0.5 mg taken 1 hour before desired , alongside behavioral scheduling, resulted in a 34-minute earlier onset compared to . Another RCT reported phase advances of 98 to 105 minutes with 0.3 to 5 mg doses administered 5 hours before baseline DLMO. A of studies on primary disorders, including DSPD, further supports a mean reduction in of 38.8 minutes with short-term use. The (AASM) endorses strategically timed low-dose as an effective option for treating DSPD in adults, emphasizing administration in the early evening to avoid disrupting the endogenous rhythm. is generally well-tolerated with short-term use, though potential side effects include headaches, daytime drowsiness, and mood alterations, necessitating monitoring during treatment. Compliance with timed dosing may be supported by behavioral strategies to reinforce the phase shift. Tasimelteon, a selective approved for non-24-hour sleep-wake disorder in totally blind individuals, is used off-label for DSPD due to its circadian-regulating properties and phase-advancing effects. In a 2023 case report of a with DSPD, tasimelteon (20 mg daily) led to an earlier shift in sleep onset and improved , with sustained benefits over several months. An ongoing multicenter, double-blind RCT is evaluating its efficacy and safety in advancing sleep-wake timing in DSPD patients, comparing 20 mg tasimelteon to over 8 weeks. Like , tasimelteon is associated with mild side effects such as and elevated liver enzymes, and AASM guidelines recommend cautious use in circadian disorders beyond its approved indication. For auxiliary sleep initiation in DSPD, low-dose (0.5 mg at bedtime) may be considered off-label to reduce sleep latency, particularly when circadian misalignment persists. However, benzodiazepines like are generally avoided as first-line agents due to risks of , dependence, and rebound with prolonged use; short-term application is preferred only if non-pharmacological methods are insufficient. Traditional hypnotics, including other benzodiazepines and Z-drugs, are similarly discouraged for chronic DSPD management owing to these issues. Emerging research explores dual orexin receptor antagonists (DORAs), such as , for DSPD by targeting wake-promoting pathways to facilitate earlier without directly altering circadian phase. An ongoing RCT is assessing (5 or 10 mg) versus for reducing in DSPD patients over 4 weeks. Preliminary evidence from 2024 studies on DORAs in suggests potential benefits for circadian-related sleep disturbances, with improvements in sleep efficiency and minimal next-day impairment, though specific DSPD outcomes remain under investigation. Side effects may include and , aligning with AASM monitoring recommendations for novel agents in circadian disorders.

Prognosis

Treatment outcomes and relapse

Treatment outcomes for delayed sleep-wake phase disorder (DSWPD) vary depending on the intervention and patient adherence, with combined therapies generally showing moderate efficacy in achieving partial circadian phase advances. Studies indicate that combined approaches, including phototherapy, chronotherapy, and pharmacological agents like , can achieve successful phase shifts, though applicability from related disorders suggests around 45% success rates. Full normalization of sleep timing to conventional schedules remains uncommon. chronotherapy, involving structured phase advances, achieves remission rates as high as 100% during treatment, but these gains are often temporary. Relapse is a significant challenge, with rates ranging from 30% to 50% within the first year post-treatment, primarily attributed to non-adherence to sleep schedules and the underlying genetic stability of the delayed . For specifically, 91.5% of patients reported relapse to pretreatment patterns within a year after discontinuation, with 28.8% relapsing within one week due to the persistence of intrinsic delays. Relapse risks are notably higher in adolescents, exceeding 50% in this group, owing to lifestyle inconsistencies and developmental factors. Recent reviews, including a 2023 update, highlight that chronotherapy and both provide advances, with combined use showing additive effects, though long-term sustainability varies and requires behavioral strategies to reduce over 6-12 months. Predictors of poor outcomes include severe delays exceeding 4 hours, presence of comorbidities such as or ADHD, and inconsistent exposure to environmental light cues, which can undermine entrainment efforts. Patients with these factors show rates up to 70%, emphasizing the need for personalized monitoring.

Long-term adaptation and quality of life

Individuals with delayed sleep phase disorder (DSPS) frequently develop long-term adaptation strategies that align their lifestyles with their inherent circadian delays, such as pursuing flexible work or school schedules that permit later start times or night shifts. These accommodations allow for better synchronization between personal rhythms and societal demands, reducing chronic sleep deprivation. Additionally, social support networks among "night owls" play a key role in coping, as individuals with evening chronotypes tend to form wider and more central social connections, providing mutual understanding and shared experiences that mitigate isolation. Quality of life in untreated DSPS is notably impaired, with patients exhibiting significantly lower scores on the Medical Outcomes Study Short Form-36 (SF-36) health survey across multiple domains, including physical functioning, mental health, and vitality, compared to age- and gender-matched norms. Post-treatment interventions, such as melatonin administration, have been shown to substantially improve these SF-36 scores, enhancing overall well-being in key subscales like vitality and emotional role functioning. However, persistent challenges remain, particularly in interpersonal relationships, where mismatched sleep schedules can strain family dynamics and romantic partnerships, leading to ongoing emotional distress and reduced relational satisfaction. As individuals with DSPS age, the disorder's impact may evolve; symptoms often improve spontaneously due to age-related advances in circadian timing, potentially shifting toward a more conventional or even advanced sleep phase, though the delay can remain stable if lifestyle tolerances are maintained. Recent 2025 patient-reported outcome studies highlight higher satisfaction levels among those who accept their and adapt accordingly, compared to attempts at forced alignment with standard schedules, which correlate with greater declines in over two-year follow-ups.

Epidemiology

Prevalence and demographics

Delayed sleep phase disorder (DSPS), also known as delayed sleep-wake phase disorder (DSWPD), exhibits varying prevalence across populations, with estimates in the general adult population ranging from 0.17% to 1.5%. Broader surveys incorporating self-reported symptoms suggest rates up to 10% when including milder forms, though diagnosed cases remain lower. In contrast, self-identified evening chronotypes—individuals with a natural preference for later sleep and wake times, which overlaps with DSPS risk—are reported in 20-30% of young adults, highlighting a spectrum from typical preferences to clinical disorder. Prevalence peaks during and young adulthood, affecting 7-16% of this group, often due to developmental shifts in circadian rhythms. Rates decline sharply after age 30, dropping to around 3% in middle-aged adults, and DSPS is rare in children under 10 or the elderly, where advanced phases predominate. Gender differences show a slight predominance, with a of approximately 1.5:1, potentially influenced by behavioral factors such as greater evening-oriented lifestyles among men. Some studies note no overall significant disparity, but clinical samples often report higher rates in young s. Genetic factors contribute to prevalence patterns, though detailed heritability is explored elsewhere.

Risk factors

Delayed sleep phase disorder (DSPS) is influenced by several non-genetic risk factors, including excessive evening light exposure from electronic screens, which suppresses production and delays the . Adolescents with DSPS often experience higher levels of evening light exposure between 10:00 PM and 2:00 AM compared to those without the disorder, contributing to a later onset. Similarly, irregular schedules, common among shift workers and students, can exacerbate phase delays by disrupting consistent circadian entrainment. students with irregular sleep-wake patterns exhibit delayed circadian rhythms, increasing susceptibility to DSPS. Developmental factors during significantly heighten the risk, as endogenous circadian naturally occur in 7-16% of adolescents and young adults. This pubertal shift is often worsened by lifestyle choices such as and consumption, which further postpone onset and intensify daytime sleepiness. For instance, intake in the evening blocks receptors, prolonging alertness and interfering with propensity in teens prone to DSPS. Environmental influences also play a role, particularly in high-latitude regions where reduced winter daylight limits morning exposure needed for advancement, leading to greater during colder months. night similarly promotes compared to rural settings without artificial illumination, as constant evening exposure mimics prolonged daylight and shifts the sleep-wake cycle later. Evening screen use is associated with delayed sleep onset and increased risk of sleep disturbances, with effects more pronounced in adolescents due to blue light's impact on melatonin suppression.

History

Early recognition

The recognition of delayed sleep phase syndrome (DSPS), now known as delayed sleep-wake phase disorder, began in the late through clinical observations of patients exhibiting persistent delays in their sleep-wake cycles, often misdiagnosed as primary or behavioral issues. Early case studies from sleep clinics highlighted individuals who were unable to initiate sleep before 2–6 a.m. and struggled with morning , despite adequate sleep duration when allowed to follow their natural rhythm. These reports, primarily from psychiatric and settings, noted frequent associations with disturbances and social impairments, particularly among adolescents and young adults. In 1981, Elliot D. Weitzman and colleagues at formally coined the term "delayed sleep phase syndrome" based on chronobiological evaluations of 11 patients, describing it as a disorder of the circadian timing where the endogenous is stably delayed by more than two hours relative to conventional societal norms. This seminal work emphasized the role of altered response curves in the circadian pacemaker, distinguishing DSPS from transient disruptions like and linking it to potential psychiatric correlates such as . The study utilized constant routine protocols to confirm the delayed timing of core body temperature and rhythms, establishing DSPS as a distinct chronobiological entity rather than a psychological failing. The syndrome received official classification in 1987 with its inclusion in the DSM-III-R as "delayed sleep phase type" under the category of sleep-wake disorders, a subtype of dyssomnias, which underscored its separation from other insomnias and required evidence of a persistent mismatch between the individual's and environmental demands. This diagnostic framework facilitated broader clinical awareness by specifying criteria such as inability to advance sleep onset voluntarily and normal sleep quality when aligned with the delayed . Concurrently, Thomas A. Wehr's 1980s on human circadian and free-running rhythms in controlled environments provided supporting evidence for the underlying mechanisms of phase delays observed in DSPS cases. A pivotal contribution to early recognition came from Michael J. Thorpy's 1988 investigation into adolescent presentations of DSPS, which documented 22 cases where delayed sleep onset interfered with school attendance and led to secondary psychological distress, advocating for chronotherapeutic interventions tailored to this demographic. These foundational efforts highlighted DSPS's prevalence in youth and its distinction from lifestyle choices, paving the way for later diagnostic refinements.

Advances in research and classification

The , Second Edition (ICSD-2), published in 2005 by the , established diagnostic criteria for delayed sleep phase disorder (DSPS), now termed delayed sleep-wake phase disorder (DSWPD), as a persistent delay in the major of more than two hours relative to conventional or socially acceptable sleep-wake times, confirmed via sleep logs or over at least seven days. This emphasized the disorder's intrinsic nature, distinguishing it from situational delays and requiring evidence of significant distress or impairment in social, occupational, or other areas of functioning. The ICSD-2 also categorized severity based on the degree of delay and impairment, with mild cases involving a two-hour shift and minimal disruption. The third edition (ICSD-3), released in 2014, refined these criteria to include objective confirmation of a delayed circadian , typically through assessment of the dim light melatonin onset (DLMO), a reliable of endogenous circadian timing that occurs later than desired in DSWPD patients. This update improved diagnostic specificity by requiring evidence of circadian misalignment beyond subjective reports, such as a DLMO occurring at least two hours later than societal norms, and excluded cases attributable to other sleep disorders or substances. The ICSD-3-TR (text revision, 2023) further clarified that DLMO testing, while not mandatory, enhances accuracy in ambiguous cases, reflecting growing consensus on integrating physiological measures into classification. In the , genetic research advanced understanding of DSWPD's through identification of variants in core genes, notably a dominant in CRY1 reported in 2017, which lengthens the circadian period and impairs transcriptional repression in the , leading to familial delayed phase. This breakthrough provided mechanistic evidence for the disorder's , with affected individuals exhibiting onsets delayed by several hours and reduced phase-advancing capacity. Building on this, genome-wide association studies (GWAS) in the have linked polygenic risk scores for evening —characterized by late preferences—to DSWPD susceptibility, identifying over 350 loci influencing circadian timing and reinforcing the between extreme chronotypes and clinical disorder. Therapeutic advancements in the 2010s included randomized controlled trials (RCTs) demonstrating the efficacy of timed administration, with a 2010 of double-blind studies showing that 0.5–5 mg doses taken 5–7 hours before habitual onset advanced the sleep phase by approximately 1.25 hours on average, reducing sleep-onset latency without significant adverse effects. Subsequent RCTs in the mid-2010s combined with behavioral scheduling, achieving sustained phase advances of up to 2 hours in adolescents and adults. By 2024–2025, research has shifted toward digital interventions, such as app-based adapted for DSWPD, with pilot studies reporting improved timing and reduced daytime impairment through personalized light exposure and chronotherapy reminders. Emerging evidence from 2024 studies also highlights stronger associations between DSWPD and depressive symptoms in youth, with 13 of 15 studies showing greater severity, and ongoing trials of novel agents like for phase advancement. Societal recognition of DSWPD has grown since the , driven by mobile apps like sleep trackers that educate users on chronotypes and media coverage framing "night owls" as a legitimate biological variation rather than . This awareness has extended to workplaces, with advocacy for chronotype-based accommodations such as flexible start times, which studies indicate can enhance and for evening types. Organizations like the Circadian Sleep Disorders Network have amplified these efforts, promoting policy changes for equitable scheduling.

References

  1. [1]
    Delayed Sleep Phase Disorder - Sleep Foundation
    Feb 14, 2024 · Delayed sleep phase disorder (DSPD), or delayed sleep-wake phase syndrome, is characterized by the inability to fall asleep, difficulty waking up on time.Missing: authoritative | Show results with:authoritative
  2. [2]
    Delayed sleep–wake phase disorder and its related sleep behaviors ...
    May 19, 2023 · DSWPD is a sleep disorder in which the habitual sleep–wake timing is delayed, resulting in difficulty in falling asleep and waking up at the desired time.Missing: authoritative sources
  3. [3]
    Delayed sleep phase - Symptoms and causes - Mayo Clinic
    Sep 21, 2023 · Delayed sleep phase is a sleep disorder that affects the internal clock, known as circadian rhythm. People with this sleep disorder have sleep patterns that ...Missing: authoritative sources
  4. [4]
    Delayed Sleep Phase Syndrome (DSPS) - Stanford Health Care
    DSPS is a disorder in which a person's sleep is delayed by two hours or more beyond what is considered an acceptable or conventional bedtime.Missing: authoritative sources
  5. [5]
    Mutation of the Human Circadian Clock Gene CRY1 in Familial ...
    A variation in the human circadian clock gene CRY1 is associated with a familial form of Delayed Sleep Phase Disorder, providing genetic underpinnings for “ ...Missing: treatment | Show results with:treatment<|control11|><|separator|>
  6. [6]
    Therapeutics for Circadian Rhythm Sleep Disorders - PMC
    Limited data suggests that the prevalence rate is about 1.7% in the general population [13] and 7% of those with insomnia complaints [7].
  7. [7]
    Circadian Rhythm Sleep Disorders: Genetics, Mechanisms, and ...
    In this review, we will summarize the recent advances in the genetics, underlying mechanisms and the adverse effects on health of ASPD and DSPD.Missing: treatment | Show results with:treatment
  8. [8]
    Updates and confounding factors in delayed sleep–wake phase ...
    Mar 2, 2023 · Exogenous melatonin administration is the recommended treatment for DSWPD under the 2015 American Academy of Sleep Medicine guidelines [52] and ...
  9. [9]
    Treatment of Circadian Rhythm Sleep–Wake Disorders - PMC
    Common treatments for CRSWD currently include sleep health education, time therapy, light therapy, melatonin, and hypnotic drug therapy.
  10. [10]
    Efficacy and safety of supplemental melatonin for delayed sleep ...
    Evidence has been provided that melatonin is an efficacious and safe chronobiotic drug for the treatment of DSPD in children.
  11. [11]
    Delayed Sleep Phase Syndrome: A common sleep disorder in ... - NIH
    Mar 12, 2019 · It is defined by the International Classification of Sleep Disorders (ICSD) as a circadian rhythm disorder including a delay in the onset of ...
  12. [12]
    AASM | International Classification of Sleep Disorders
    Aug 13, 2024 · Sleep disorders are grouped into six major categories in the ICSD-3-TR: Insomnia Disorders; Sleep-Related Breathing Disorders; Central Disorders ...
  13. [13]
    [PDF] Circadian Rhythm Sleep-Wake Disorders
    Delayed sleep-wake phase disorder must be distinguished from “normal” sleep patterns, particularly in adolescents and young adults who maintain delayed ...
  14. [14]
    Current Considerations in the Diagnosis and Treatment of Circadian ...
    The diagnostic criteria for the 4 intrinsic Circadian Rhythm Sleep-Wake Disorders (CRSWDs), Delayed Sleep-Wake Phase Disorder ... (ICSD-3-TR), sleep logs ...
  15. [15]
    Light-based methods for predicting circadian phase in delayed ...
    May 25, 2021 · This study evaluated two methods for predicting dim light melatonin onset (DLMO) in 154 DSWPD patients using ~ 7 days of sleep–wake and light data.Phase Predictions · Methods · Circadian Phase Assessment
  16. [16]
    Evaluation of two circadian rhythm questionnaires for screening for ...
    Sep 6, 2012 · This study was to evaluate these two chronotype questionnaires for screening of DSPD. Methods: The study samples were 444 DSPD and 438 controls.
  17. [17]
    Association between the Munich Chronotype Questionnaire and ...
    May 9, 2018 · Measuring chronotype is helpful to diagnose circadian rhythm sleep-wake disorders. The Munich Chronotype Questionnaire (MCTQ) is a self-reported ...<|separator|>
  18. [18]
    [PDF] Delayed Sleep Phase Syndrome - American Thoracic Society
    DSPS is a disorder in which a person's bedtime is delayed by 2 or more hours beyond the socially acceptable or usual bedtime for people of the same age. If you ...Missing: definition authoritative
  19. [19]
    Delayed sleep-wake phase disorder - Journal of Thoracic Disease
    In essence, people with the disorder have an abnormally delayed major sleep episode relative to the dark phase of the solar cycle, and hence great difficulty ...
  20. [20]
    Delayed Sleep Phase Syndrome (DSPS): Symptoms & Treatment
    Delayed sleep phase syndrome is a condition that affects your ability to fall asleep and wake up. The delay to your sleep is more than two hours past your ...Missing: ICSD- | Show results with:ICSD-
  21. [21]
    A prospective study of delayed sleep phase syndrome in patients ...
    Patients with DSPS were significantly more disabled in their social and occupational functioning than those with a normal sleep. It is uncertain whether this is ...
  22. [22]
    Delayed sleep-wake phase disorder in a clinical population
    Delayed sleep-wake phase disorder (DSWPD) is defined by a delay in the major sleep episode relative to desired or required sleep and wake times.<|control11|><|separator|>
  23. [23]
    The impact of delayed sleep phase disorder on adolescents and ...
    The impact of delayed sleep phase disorder on adolescents and their family ... (3) Impact on the family, conflicts, and misunderstanding: describing the ...
  24. [24]
    Late and Instable Sleep Phasing is Associated With Irregular Eating ...
    Mar 25, 2020 · Later sleep associated with a lower frequency and later and variable sleep with more irregular eating. ... Delayed Sleep Phase Disorder. Sleep.
  25. [25]
    Genetic and Environmental Contributions to Sleep-Wake Behavior ...
    The current study demonstrates an overall stronger association between the sleep habits of MZ twin pairs compared to DZ twin pairs. Maximum likelihood ...
  26. [26]
    A missense variant in PER2 is associated with delayed sleep-wake ...
    Delayed sleep-wake phase disorder (DSWPD) is a subtype of circadian rhythm sleep-wake disorders, and is characterized by an inability to fall asleep until late ...
  27. [27]
    A length polymorphism in the circadian clock gene Per3 is linked to ...
    Study objectives: To investigate the link between extreme diurnal preference, delayed sleep phase syndrome, and a length polymorphism in Per3.
  28. [28]
    Genome-wide association analyses of chronotype in ... - Nature
    Jan 29, 2019 · In this study, we perform a GWAS meta-analysis of a substantially expanded set of 697,828 individuals, including 248,098 participants from ...Missing: RORB | Show results with:RORB
  29. [29]
    Melatonin, cortisol and thyroid-stimulating hormone rhythms are ...
    Jul 28, 2016 · The hormonal rhythms were significantly delayed in patients with DSPS compared with controls, whereas the 24-h amounts of hormonal secretions ...
  30. [30]
    SLEEP TIMING AND CIRCADIAN PHASE IN DELAYED ... - NIH
    Delayed sleep phase syndrome (DSPS) is a circadian rhythm sleep disorder in which the timing of the sleep episode occurs later than desired and is associated ...
  31. [31]
    [PDF] Delayed sleep phase syndrome: the sleep disorder that's out of sync
    Sep 4, 2025 · Functional magnetic resonance imaging (fMRI). Studies have used fMRI to investigate changes in brain activity and connectivity during DSPS.3.
  32. [32]
    Prevalence of Circadian Misalignment and Its Association With ...
    Jan 25, 2017 · Depressive symptoms are commonly reported in DSPD patients. ... Abe and colleagues showed that 64% of patients with DSPD had a comorbid diagnosis ...
  33. [33]
    Delayed sleep-wake rhythm is associated with cognitive dysfunction ...
    Nov 6, 2022 · Several studies suggested that depressive symptoms were common in patients with delayed sleep-wake phase disorder (22, 23).Abstract · Introduction · Materials and methods · Discussion
  34. [34]
    The Association Between Delayed Sleep-Wake Phase Disorder and ...
    Mar 24, 2025 · Thirteen out of 15 studies demonstrated that young individuals with DSWPD had a significantly greater severity of depressive symptoms than young individuals ...
  35. [35]
    ADHD and Sleep Disorders: Clinical Insights into Pathophysiology ...
    May 29, 2024 · The prevalence of Delayed Sleep Phase Syndrome (DSPS) in ADHD is between 26%-78%, which is significantly higher than the general population.
  36. [36]
    Sleep disorders in patients with ADHD: impact and management ...
    Dec 14, 2018 · Evening chronotype was associated with more resistance to sleep, respiratory problems, and daytime sleepiness. Adolescents. Individuals with ...
  37. [37]
    Sleep disturbances in obsessive-compulsive disorder: influence of ...
    Jan 14, 2021 · Our findings support the existence of sleep disturbances in OCD. Trait anxiety and depression play a key role in sleep quality among OCD patients.
  38. [38]
    Delayed circadian rhythms and insomnia symptoms in obsessive ...
    Dec 1, 2022 · These findings highlight a robust association between delayed circadian rhythms and OCD and suggest insomnia symptoms may be one mechanism in this relationship.
  39. [39]
    Sleep and circadian disruption in bipolar disorders: From ...
    Aug 30, 2024 · 116Disturbed sleep as risk factor for the subsequent onset of bipolar disorder – Data from a 10-year prospective-longitudinal study among ...
  40. [40]
    Circadian rhythm dysfunction and psychopathology in the offspring ...
    May 22, 2024 · In terms of the emergence of symptoms, there was a marginally significant association of parental history of bipolar disorder with delayed sleep ...
  41. [41]
    Delayed sleep phase: An important circadian subtype of sleep ...
    Sleep disturbances in bipolar disorders (BD) may occur in 30–60% of cases, and they are increasingly recognized as important prognostic indicators (Harvey, 2008 ...
  42. [42]
    The role of insufficient sleep and circadian misalignment in obesity
    Oct 24, 2022 · Insufficient sleep and circadian misalignment predispose individuals to poor metabolic health and promote weight gain.
  43. [43]
    Sleep & circadian health are associated with mood & behavior in ...
    A bidirectional relationship between sleep and overweight/obesity has been reported, with insufficient and delayed sleep a risk factor for overweight/obesity in ...
  44. [44]
    A review of sleep disturbances following traumatic brain injury
    Feb 16, 2018 · The prevalence of insomnia following TBI is varied, with anywhere from 10 to 84% of patients reporting insomnia symptoms up to three years ...Hypersomnia · Circadian Rhythm Disorders · Narcolepsy<|separator|>
  45. [45]
    Delayed Sleep Phase Disorder After Traumatic Brain Injury - PubMed
    The authors report a case in which a sleep-wake schedule disorder arose after a closed head injury.Missing: post- | Show results with:post-
  46. [46]
  47. [47]
    From Lockdowns to Long COVID—Unraveling the Link ... - NIH
    Jul 28, 2025 · Results: Participants with long COVID symptoms reported significantly poorer sleep quality, higher perceived stress, greater somatic and ...
  48. [48]
    Cardiovascular risk in adults with Delayed Sleep Phase Syndrome ...
    Dec 2, 2023 · Cardiovascular risk in adults with Delayed Sleep Phase Syndrome (DSPS) and Attention-Deficit/Hyperactivity Disorder (ADHD) · Abstract.
  49. [49]
    Role of Circadian Health in Cardiometabolic Health and Disease Risk
    Oct 28, 2025 · A nondipping pattern is associated with an increased risk of CVD events (15%) and mortality (22%), with higher risk noted in patients with ...
  50. [50]
    Delayed Sleep-Wake Phase Disorder & Behaviors in Youth
    DSWPD is a sleep disorder in which the habitual sleep–wake timing is delayed, resulting in difficulty in falling asleep and waking up at the desired time.
  51. [51]
    Sleeplessness and Circadian Rhythm Disorder Workup
    Apr 3, 2025 · ... (ICSD-3-TR), all circadian rhythm sleep-wake disorders must meet three key criteria: Disrupted sleep-wake rhythm: A persistent or ...
  52. [52]
    Evaluation of Two Circadian Rhythm Questionnaires for Screening ...
    Circadian chronotype questionnaires such as Horne-Östberg Morningness-Eveningness Questionnaire (MEQ) and Basic Language Morningness (BALM) scale have been ...
  53. [53]
    Delayed Sleep-Wake Phase Disorder: Can Polysomnography Be ...
    Aug 7, 2025 · The aim of our study was to compare data from clinical interviews, sleep diaries, actigraphy and nocturnal polysomnography (PSG) in a cohort of ...
  54. [54]
    Practice Parameters for the Clinical Evaluation and Treatment of ...
    The main diagnostic tools considered include sleep logs, actigraphy, the Morningness-Eveningness Questionnaire (MEQ), circadian phase markers, and ...
  55. [55]
    Recommendations for permanent sleep telehealth
    Telehealth is an essential tool for providing sleep medicine services. Home sleep apnea test coordination, clinical consultations, cognitive behavioral therapy ...
  56. [56]
    Delayed sleep-wake phase disorder - UpToDate
    Jul 14, 2025 · ... criteria for delayed sleep-wake phase disorder (ICSD-3-TR)Consensus Sleep DiaryConsensus Sleep Diary instructionsChronic insomnia: Examples ...
  57. [57]
    Non-24-Hour Sleep-Wake Disorder - Circadian Rhythm Disorder
    Comparisons may be useful for differential diagnosis. Delayed sleep-wake phase disorder (DSPD) is a circadian rhythm disorder, far more common than N24, in ...
  58. [58]
    Circadian rhythm sleep disorders: characteristics and ... - PubMed
    This paper presents a clinical review of delayed sleep phase syndrome (DSPS) and non-24-h sleep-wake syndrome (non-24). These syndromes seem to be common ...
  59. [59]
    Common Sleep Disorders in Adults: Diagnosis and Management
    A sleep-wake schedule and melatonin or a bright-light therapy regimen is recommended for treatment of delayed sleep phase syndrome. B, American Academy of Sleep ...Abstract · Diagnosis · Problems Falling Asleep · Behavior and Movement...
  60. [60]
    'It's not insomnia': Shining a light on delayed sleep phase syndrome
    Nov 6, 2019 · Another way to manage this condition is to encourage patients with delayed sleep phase syndrome to factor in extra time to snooze when possible ...
  61. [61]
    Sleeplessness and Circadian Rhythm Disorder Differential Diagnoses
    Apr 3, 2025 · Advanced sleep-phase disorders should be differentiated from atypical depression, seasonal affective disorder, and excessive daytime sleepiness ...
  62. [62]
    Definitions - Circadian Sleep Disorders Network
    May 11, 2025 · Delayed Sleep-Phase Disorder (DSPD), also called Delayed Sleep Phase Syndrome (DSPS), is a circadian sleep disorder in which the individual's ...
  63. [63]
    A Clinical Approach to Circadian Rhythm Sleep Disorders - PMC
    Current treatment options for DSPD include chronotherapy, timed bright light exposure and melatonin. Exogenous melatonin is widely available as a nutritional ...
  64. [64]
    resetting the circadian clocks of patients with delayed sleep phase ...
    Chronotherapy was therefore designed to reset these patients' biological clocks by the phase delay route. This single 5-6 day treatment was tested in 5 patients ...
  65. [65]
    Long-term course of adult patients with delayed sleep phase ...
    Six patients treated with chronotherapy showed full recovery just after the treatment. In three of them the delay of sleep phase relapsed one year afterwards.
  66. [66]
    Light therapy for the treatment of delayed sleep-wake phase ...
    Light therapy for the treatment of delayed sleep-wake phase disorder in adults: a systematic review. Sleep Sci. 2021 Apr-Jun;14(2):155-163. doi: 10.5935/1984 ...
  67. [67]
    Developing a cognitive behavioral therapy manual for delayed sleep ...
    This article reports the development of a treatment protocol, based on cognitive behavioral therapy (CBT) principles, for delayed sleep-wake phase disorder ...
  68. [68]
    A Randomized Controlled Trial of Cognitive-Behavior Therapy Plus ...
    Dec 1, 2011 · CBT plus BLT for adolescent DSPD is effective for improving multiple sleep and daytime impairments in the immediate and long-term.
  69. [69]
    Mobile App for Digital Chronotype & Delayed Chronotype Effects
    Development of a mobile application (App) to delineate "digital chronotype" and the effects of delayed chronotype by bedtime smartphone use. J Psychiatr Res ...
  70. [70]
    Current and Future Perspectives on Light Therapy Using Wearable ...
    Sep 5, 2021 · Because light is the most important “zeigeber” for synchronizing the circadian system, light therapy is effective for circadian rhythm sleep ...
  71. [71]
    Low-dose exogenous melatonin plus evening dim light and time in ...
    In this randomized, controlled, double-blind trial, 40 adults with delayed sleep-wake phase disorder were randomly assigned to 4 weeks of 0.5 mg timed to be ...
  72. [72]
    Efficacy of melatonin with behavioural sleep-wake scheduling for ...
    Jun 18, 2018 · This trial tested the efficacy of 0.5 mg melatonin, combined with behavioural sleep-wake scheduling, for improving sleep initiation in clinically diagnosed ...
  73. [73]
    The efficacy and safety of exogenous melatonin for primary sleep ...
    There is some evidence to suggest that melatonin is effective in treating delayed sleep phase syndrome with short-term use. There is evidence to suggest ...
  74. [74]
    New clinical guideline to help clinicians treat circadian rhythm sleep ...
    Oct 5, 2017 · A new clinical practice guideline published by the American Academy of Sleep Medicine provides clinicians with updated recommendations for the treatment of ...Missing: pharmacological | Show results with:pharmacological
  75. [75]
    Delayed Sleep-Wake Phase - Sleep Education by the AASM
    May 6, 2021 · How to treat delayed sleep-wake phase disorder? Strategically timed low dose melatonin use has been shown to be an effective treatment option in ...Missing: pharmacological | Show results with:pharmacological
  76. [76]
    Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep ...
    This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo.
  77. [77]
    Case report: A patient with Delayed Sleep-Wake Phase Disorder ...
    Nov 13, 2023 · This case illustrates the general positive effect of tasimelteon on a participant diagnosed with DSWPD, based on earlier sleep onset shift ...
  78. [78]
    [PDF] Clinical Practice Guideline for the Treatment of Intrinsic Circadian ...
    Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake ...
  79. [79]
    [PDF] Benzodiazepines for the treatment of sleep disorders
    The benzodiazepine clonazepam at doses of 0.5 mg to 2 mg per night, reduces periodic movements and associated symptoms of insomnia and excessive daytime ...
  80. [80]
  81. [81]
    Clinical usefulness of dual orexin receptor antagonism beyond ...
    Mar 1, 2024 · This review synthesizes evidence on DORAs in psychiatric and neurological disorders. Treating insomnia by DORA can positively impact neurologic and psychiatric ...
  82. [82]
    Inpatient phase-advance therapy for delayed sleep–wake ... - NIH
    Oct 12, 2018 · The rate of DSWPD remission under inpatient phase-advance therapy was remarkably high (100%), while the rate of relapse after discharge was ~50%.
  83. [83]
    Delayed sleep phase disorder - Wikipedia
    The disorder affects the timing of biological rhythms including sleep, peak period of alertness, core body temperature, and hormonal cycles.Mechanism · Diagnosis · Management · Prognosis
  84. [84]
    Updates and confounding factors in delayed sleep–wake phase ...
    Mar 2, 2023 · This review collates what is known on the causes and treatments of DSWPD, addresses the pitfalls in diagnosis and discusses the implications of current data.
  85. [85]
    [PDF] Circadian Rhythm Sleep Disorders
    Delayed sleep phase disorder (DSP):. DSP occurs when a person regularly goes ... night shifts and early- morning shifts. Effects. These are some of the ...
  86. [86]
    Night owls have larger social networks than early birds - ScienceDaily
    Dec 7, 2017 · Night owls -- people who go to sleep late -- tend to have wider social networks than morning persons. Night owls are also more central in their own networks.
  87. [87]
    Effects of melatonin on the quality of life in patients with delayed ...
    DSPS has a unique significant quality-of-life burden that seems to be improved by treatment with melatonin.
  88. [88]
    Impacts of aging on circadian rhythm and related sleep disorders
    Dec 29, 2023 · Aging worsens the "morningness" of FASPS disorder patients and improves the symptoms of DSPS disorder patients. This study helps to better ...
  89. [89]
    A 2-year follow-up study on the course of at-risk delayed sleep-wake ...
    Sep 18, 2025 · ... quality of life declines. Additionally, although the improved group ... RajaratnamSMW et al. Delayed sleep phase disorder risk is associated with ...
  90. [90]
    How do youth with Delayed Sleep-Wake Phase Disorder experience ...
    Jun 12, 2025 · ... social isolation. Accordingly, DSWPD has shown to negatively affect ... delayed sleep phase disorder in young adults: a randomized controlled ...
  91. [91]
    Chronotypes and its association with psychological morbidity ... - NIH
    Intermediate chronotype was the most common, seen in 87 (58%) students, followed by evening type in 34 (22.7%). Evening types have more difficulties in making a ...
  92. [92]
    Delayed sleep–wake phase disorder in young adults: prevalence ...
    Danielsson et al. Delayed sleep phase disorder in a Swedish cohort of ... quality of life in adolescents: Evidence from the SCAMP longitudinal cohort study.
  93. [93]
    Delayed Sleep-Wake Phase Disorder in a Clinical Population
    In this clinical population, DSWPD is more prevalent in young men and in middle age women, although with no overall significant differences between genders.
  94. [94]
    Delayed sleep phase disorder during the COVID-19 pandemic and ...
    Circadian rhythm sleep disorders are alterations that are characterized by a shift in the sleep-wake cycle relative to day and night, such as the delayed sleep ...
  95. [95]
    Delayed sleep phase syndrome. A chronobiological disorder with ...
    Six patients' histories are described in detail, including the successful nonpharmacological chronotherapy regimen (resetting the patients' biological clock by ...
  96. [96]
    Delayed Sleep Phase Disorder after Traumatic Brain Injury
    The authors report a case in which a sleep-wake schedule disorder arose after a closed head injury.
  97. [97]
    Delayed sleep phase syndrome in adolescents - PubMed
    The delayed sleep phase syndrome is characterized by difficulty in falling asleep at a socially acceptable time of night and an inability to be easily aroused ...Missing: Michael | Show results with:Michael
  98. [98]
    [PDF] Guideline Update - American Academy of Sleep Medicine
    Delayed sleep phase disorder (DSPD) is characterized by a stable delay of the ... Phase-dependent treatment of delayed sleep phase syndrome with melatonin.
  99. [99]
    Error
    No readable text found in the HTML.<|separator|>
  100. [100]
    The use of exogenous melatonin in delayed sleep phase disorder
    Study objectives: To perform a meta-analysis of the efficacy and safety of exogenous melatonin in advancing sleep-wake rhythm in patients with delayed sleep ...Missing: DSPS | Show results with:DSPS
  101. [101]
    Efficacy of melatonin with behavioural sleep-wake scheduling for ...
    This trial tested the efficacy of 0.5 mg melatonin, combined with behavioural sleep-wake scheduling, for improving sleep initiation in clinically diagnosed ...
  102. [102]
    Piloting a brief digital behavioral intervention for adolescent sleep
    Oct 31, 2025 · A randomized controlled trial of cognitive-behavior therapy plus bright light therapy for adolescent delayed sleep phase disorder. Sleep.
  103. [103]
    Delayed sleep phase disorder during the COVID-19 pandemic and ...
    Feb 28, 2023 · The prevalence of DSPD in young adults is 0.48%, increasing to 3.3% in adolescents. Interestingly, patients with COVID-19 infection report ...
  104. [104]
    Maybe Your Sleep Problem Isn't a Problem - The New York Times
    Aug 25, 2018 · It's the old “dress like your boss” formula for success, but with chronotypes, not clothes. But what if the modern-day workplace no longer ...Call It D.S.P.S · Hacker Hours · The End Of Larks?
  105. [105]
    Worker Productivity Depends on Chronotype
    Dec 1, 2023 · "Meanwhile, workers should be aware of their preferences and consider seeking accommodations or advocating for flexible work arrangements to ...
  106. [106]
    Circadian Sleep Disorders Network
    Circadian Sleep Disorders Network is an independent nonprofit organization dedicated to improving the lives of people with chronic circadian rhythm disorders.DSPD Q&A · Definitions · Info & Links · Find a Doctor